Omeros Corp. (OMER) stock plunge during current market trading. What’s driving it low?
Omeros Corp. (NASDAQ: (OMER) stock declines by 43.22% in the current market trading session. Omeros is a commercial-stage pharmaceutical business focused on finding, manufacturing, and commercializing small-molecule and protein therapies for huge market and orphan indications in inflammation, immunologic illnesses (e.g., complement-mediated diseases and malignancies), and CNS disorders. In cataract surgery, its successful product OMIDRIA […]
Omeros Corp. (OMER) stock plunge during current market trading. What’s driving it low? Read More »